The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals and access to digital therapies, and the growing importance of technologies such as artificial intelligence (AI), the internet of things (IoT), augmented reality (AR), robotics and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Environment Sustainability in Healthcare: Automated immunoassay analyzer. Buy the report here.
According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.
Automated immunoassay analyser is a key innovation area in environmental sustainability
Utilising an antibody as a reagent, immunoassay analysers are used to locate and measure the quantity of certain chemicals in a sample. These tools are employed in hospitals and clinical labs to carry out several tests, such as those for cancer, allergies, therapeutic pharmaceutical monitoring, and other conditions. Because automated immunoassay analysers use less raw materials and involve less human error (having to repeat the test), they are assumed to have a better impact on the environment compared to traditional testing.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 80 companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of automated immunoassay analyser.
Key players in automated immunoassay analyser – a disruptive innovation in the healthcare industry
Patent volumes related to automated immunoassay analyser
|Company||Total patents (2010 - 2022)||Premium intelligence on the world's largest companies|
|Vanda Pharmaceuticals||142||Unlock Company Profile|
|Labrador Diagnostics||97||Unlock Company Profile|
|F. Hoffmann-La Roche||89||Unlock Company Profile|
|Caris MPI||75||Unlock Company Profile|
|Omni MedSci||47||Unlock Company Profile|
|Johnson & Johnson||47||Unlock Company Profile|
|Boston Medical Center||46||Unlock Company Profile|
|Biodesix||46||Unlock Company Profile|
|Waters||43||Unlock Company Profile|
|MeMed Diagnostics||39||Unlock Company Profile|
|Nestle||36||Unlock Company Profile|
|Gritstone Bio||35||Unlock Company Profile|
|Compagnie Merieux Alliance||34||Unlock Company Profile|
|OPKO Health||31||Unlock Company Profile|
|Idexx Laboratories||27||Unlock Company Profile|
|Coloright||26||Unlock Company Profile|
|Abbott Laboratories||26||Unlock Company Profile|
|Takeda Pharmaceutical||25||Unlock Company Profile|
|Cleveland Clinic Foundation||25||Unlock Company Profile|
|St. Jude Children’s Research Hospital||24||Unlock Company Profile|
|Royal Caribbean Cruises||22||Unlock Company Profile|
|Reliant Immune Diagnostics||21||Unlock Company Profile|
|Psomagen||21||Unlock Company Profile|
|Samsung Group||20||Unlock Company Profile|
|Globeimmune||18||Unlock Company Profile|
|Veracyte||16||Unlock Company Profile|
|Genocea Biosciences||16||Unlock Company Profile|
|Meridian Bioscience||15||Unlock Company Profile|
|Neste||15||Unlock Company Profile|
|Sysmex||14||Unlock Company Profile|
|Agios Pharmaceuticals||14||Unlock Company Profile|
|Vertex Pharmaceuticals||13||Unlock Company Profile|
|Bio-Rad Laboratories||13||Unlock Company Profile|
|Pacific Edge||13||Unlock Company Profile|
|Siemens||12||Unlock Company Profile|
|Nanjing Xinjiekou Department Store||12||Unlock Company Profile|
|Immunovia||12||Unlock Company Profile|
|True Health Diagnostics||12||Unlock Company Profile|
|ChipCare||11||Unlock Company Profile|
|Cell ID||11||Unlock Company Profile|
|Carmentix||11||Unlock Company Profile|
|Integrated Health Leaders||11||Unlock Company Profile|
|Vyripharm Enterprises||10||Unlock Company Profile|
|Clalit Health Services||10||Unlock Company Profile|
|Fujifilm Holdings||9||Unlock Company Profile|
|Androvia LifeSciences||9||Unlock Company Profile|
|Koninklijke Philips||9||Unlock Company Profile|
|Metamark Genetics||9||Unlock Company Profile|
|ProteomikaSL||9||Unlock Company Profile|
|Exact Sciences||8||Unlock Company Profile|
Source: GlobalData Patent Analytics
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Vanda Pharmaceuticals is one of the leading patent filers in the field of automated immunoassay analyser. Some other key patent filers in the field include Labrador Diagnostics and F. Hoffmann-La Roche.
In terms of application diversity, Agios Pharmaceuticals leads the pack, followed by Boston Medical Center and Fujifilm, respectively. By means of geographic reach, Idexx Laboratories held the top position, followed by OPKO Health and Vertex Pharmaceutical in second and third spots, respectively.
In the foreseeable future, several applications for automated immunoassay analysers will spur corporate growth. Its widespread application in environmental sample assessment could support industry growth. By using automated technologies, laboratories may better allocate their qualified personnel to more crucial tasks like analysing and reviewing test findings.
To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Healthcare.